HDAC3 and B-cell non-Hodgkin lymphoma: It has also been shown that histone deacetylase 3 (HDAC3) is another important epigenetic regulator of PD-L1 in B-cell lymphoma as its inhibition increases PD-L1 transcription, resulting in a better clinical response to PD-L1 blockade [301].